Fusion Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 508 | 0.000597% |
Individual Insiders | 499,163 | 0.587% |
Public Companies | 3,256,972 | 3.83% |
VC/PE Firms | 6,825,395 | 8.02% |
General Public | 7,907,907 | 9.3% |
Hedge Funds | 12,901,328 | 15.2% |
Institutions | 53,668,692 | 63.1% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 33.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
10,811,153 | US$233.0m | -0.69% | 0.61% | |||
6,825,395 | US$147.1m | 148% | 2.98% | |||
6,500,328 | US$140.1m | 0% | 5.41% | |||
6,401,000 | US$137.9m | 0% | 2.63% | |||
4,187,271 | US$90.2m | 0% | 0.04% | |||
3,807,247 | US$82.0m | 0% | 27.68% | |||
3,781,778 | US$81.5m | 0% | 2.23% | |||
3,670,516 | US$79.1m | 0% | 17.26% | |||
3,256,972 | US$70.2m | 0% | no data | |||
3,116,966 | US$67.2m | 0% | 0.04% | |||
2,551,794 | US$55.0m | 0% | 0.18% | |||
1,836,739 | US$39.6m | -65.4% | no data | |||
1,608,882 | US$34.7m | 178% | 0.03% | |||
1,501,283 | US$32.4m | 371% | 0.06% | |||
1,003,628 | US$21.6m | 0% | 3.08% | |||
987,178 | US$21.3m | 0% | 0.04% | |||
779,202 | US$16.8m | -21.6% | 0.02% | |||
734,321 | US$15.8m | 0% | 0.02% | |||
657,385 | US$14.2m | 162% | 0.1% | |||
633,932 | US$13.7m | 2,150% | 0.02% | |||
589,725 | US$12.7m | 9,090% | 0.01% | |||
585,102 | US$12.6m | 0% | 0.65% | |||
579,769 | US$12.5m | 0% | 2.37% | |||
563,385 | US$12.1m | -63.9% | 5.39% | |||
516,795 | US$11.1m | 23.1% | no data |